Yearly Archives: 2025

First in Bosnia and Herzegovina: UKC Tuzla Implements C-RAD System for Precision Verification of Radiation Therapy

As part of advancing radiotherapy procedures, the Clinic for Oncology and Radiotherapy of the University Clinical Center Tuzla (UKC Tuzla) has introduced the state-of-the-art C-RAD system for verification and monitoring of radiation exposure. This innovative technology represents a significant step toward more precise and safer treatment of patients with malignant diseases, ensuring maximum protection of…

UKC Tuzla Introduces Innovative Surgical Technique for Aortic Aneurysm Treatment

At the University Clinical Center Tuzla (UKC Tuzla), a press conference was held to present a new advancement in vascular surgery for the treatment of aortic aneurysms, performed at the Clinic for Cardiovascular Surgery. The innovative procedure in open surgery for giant aortoiliac aneurysms, which preserves hypogastric artery flow, was developed by Prof. Dr. Dragan…

UKC Tuzla Strengthens Medical Team: Eleven Young Doctors Begin Specialization

At the University Clinical Center Tuzla (UKC Tuzla), contracts were officially signed with eleven young doctors who will begin their specialization in the fields of anesthesiology, internal medicine, and microbiology. The contract signing ceremony was attended by the Director of UKC Tuzla, Prof. Dr. Šekib Umihanić, Head of the Legal Affairs and Human Resources Sector…

University Clinical Center Tuzla Enhances Diagnostic Capacities with New Equipment

With the support of the Government of Tuzla Canton, the Department of Pathology at the Polyclinic for Laboratory Diagnostics of the University Clinical Center Tuzla (UKC Tuzla) has been equipped with state-of-the-art medical technology. The new equipment includes advanced microscopes for pathology diagnostics, a specialized workstation for microscopic sampling, an automatic slide counter with coverslip…

UKC Tuzla Eye Clinic Introduces Innovative Drug Faricimab into Clinical Practice

The Clinic for Eye Diseases at the University Clinical Center Tuzla (UKC Tuzla) has introduced faricimab, an innovative drug, into routine clinical use. Faricimab represents the latest therapeutic option for treating conditions such as neovascular (wet) age-related macular degeneration and diabetic macular edema. It is the first dual-inhibitory monoclonal antibody that targets two key pathological…